Effect of Lactiplantibacillus Plantarum DAD-13 on Inflammatory Markers in ICU Sepsis Patients

Clinical trial NCT07072871 · COMPLETED

Trial details

NCT number: NCT07072871
Sponsor: PT Royal Medikalink Pharmalab
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sepsis Systemic Inflammatory Response Syndrome (SIRS)Critical Illness

Start date: 2024-04-01
Primary completion: 2024-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.